L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)	Neoplasms by Histologic Type, basal cell carcinoma, basal cell neoplasm, carcinoma, epithelial neoplasm, neoplasm	Recruiting	Phase 2	2026-07-31		NCT07227350

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Philogen S.p.A.	15

18 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Andreas Syngros Hospital Of Venereal And Dermatological Diseases	Athens	Greece	3
Azienda Ospedaliero-Universitaria Senese	Siena	Italy	6
Charite Universitaetsmedizin Berlin KöR	Berlin	Germany	4
Duke University Medical Center	Durham	United States	505
Fondazione Policlinico Universitario Agostino Gemelli IRCCS	Roma	Italy	61
H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc.	Tampa	United States	4
Hospital Clinic de Barcelona	Barcelona	Spain	137
Humanitas Mirasole S.p.A.	Rozzano	Italy	4
Irccs Istituto Nazionale Tumori Fondazione Pascale	Naples	Italy	8
The Ohio State University Wexner Medical Center Clinical Laboratories	Columbus	United States	2
The University of Texas MD Anderson Cancer Center	Houston	United States	207
Universitaetsklinikum Augsburg	Augsburg	Germany	3
Universitaetsklinikum Essen AöR	Essen	Germany	4
Universitaetsklinikum Halle (Saale) AöR	Halle	Germany	3
Universitaetsklinikum Schleswig-Holstein AöR	Kiel	Germany	4
Universitaetsklinikum Tuebingen AöR	Tübingen	Germany	2
University Hospitals Cleveland Medical Center	Cleveland	United States	234
Winship Cancer Institute, Emory University	Atlanta	United States	47